J. Cramer

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.

B. Fox, S. Rosenberg, W. Urba, 2022, The New England journal of medicine.

Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.

W. Urba, R. Ahmad, M. Whiteford, 2022, The Lancet. Oncology.

Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis

Allison P. Heath, Marilyn M. Li, Jena V. Lilly, 2022, Scientific Reports.

A Phase II Trial of TGFβ Type I Receptor Inhibitor, Galunisertib, plus Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

W. Urba, G. Vaccaro, M. Crittenden, 2022, International Journal of Radiation Oncology*Biology*Physics.